Joint ventures/collaborations | Science and Enterprise

A solid majority of Americans express at least some doubts about biometrics for accessing computers, this weekend's… https://t.co/oUU1W1bX6E
about 16 hours ago
New post on Science and Enterprise: Infographic – Americans Leery of Biometrics https://t.co/5xslb7xRX1 #Science #Business
about 16 hours ago
Thanks @innerarchitect ... A local Arlington pub, but still beer. Enjoy the weekend. https://t.co/CpxP0ewUVC
about 18 hours ago
An electronic wearable device worn as a patch is designed to act like a personal heating or cooling system in uncom… https://t.co/wTYoZ3MZD8
about 1 day ago
New post on Science and Enterprise: Wearable Patch Designed for Personal Warmth, Cooling https://t.co/dvEVKGfKat #Science #Business
about 1 day ago

FDA Expands Evidence Project to Replace Trials

By Alan, on April 10th, 2019%

The Food and Drug Administration is expanding a demonstration project with a Boston teaching hospital that tests the value of real world evidence to replace some clinical trials. . . . → Read More: FDA Expands Evidence Project to Replace Trials

Biotechs Partner on Gene Silencing in $1.1B Deal

By Alan, on April 8th, 2019%

Two biotechnology companies plan to develop new therapies mainly for eye and neurological diseases that silence genes responsible for those conditions. . . . → Read More: Biotechs Partner on Gene Silencing in $1.1B Deal

Biotechs Join Forces for Off-the-Shelf Stem Cells

By Alan, on April 3rd, 2019%

Two biotechnology enterprises working in genome editing and regenerative medicine are sharing their technologies to develop off-the-shelf cell therapies. . . . → Read More: Biotechs Join Forces for Off-the-Shelf Stem Cells

Immuno-, Chemotherapy Shown to Shrink Pancreatic Cancers

By Alan, on April 1st, 2019%

Early results from a clinical trial show a combination of immunotherapy and chemotherapy drugs shrunk tumors in most participants with pancreatic cancer. . . . → Read More: Immuno-, Chemotherapy Shown to Shrink Pancreatic Cancers

Ancient DNA Studied for Mental Health Clues

By Alan, on March 26th, 2019%

A lab studying DNA from past civilizations and the genomics technology company Illumina are investigating remains of ancient peoples for insights into today’s neurological disorders. . . . → Read More: Ancient DNA Studied for Mental Health Clues

Celgene Adopting A.I. Drug Discovery Technology

By Alan, on March 21st, 2019%

Drug maker Celgene is gaining access to an artificial intelligence platform developed by Exscientia Ltd, to find treatment candidates for cancer and autoimmune disorders. . . . → Read More: Celgene Adopting A.I. Drug Discovery Technology

NIH Funds Natural Hearing Restoration Technology

By Alan, on March 20th, 2019%

An international group of universities and companies is designing a next-generation device to restore more natural hearing to people suffering from hearing loss. . . . → Read More: NIH Funds Natural Hearing Restoration Technology

Gates Supporting Infectious Antibody Discovery

By Alan, on March 14th, 2019%

The Bill and Melinda Gates Foundation is enlisting a company that discovers therapeutic antibodies to help researchers develop new drugs and vaccines for serious infectious diseases. . . . → Read More: Gates Supporting Infectious Antibody Discovery

Microsoft, Biotech Partner on Gene, Cell Therapies

By Alan, on March 14th, 2019%

A biotechnology company in the U.K. and U.S. software maker Microsoft are collaborating on new processes to speed development of gene and cell therapies. . . . → Read More: Microsoft, Biotech Partner on Gene, Cell Therapies

Genomics, A.I. Calculate Immune Health

By Alan, on March 12th, 2019%

An international team designed a technique to gauge a person’s immune system age and health, by analyzing genomic and cellular indicators with machine-learning algorithms. . . . → Read More: Genomics, A.I. Calculate Immune Health

Science & Enterprise subscription

Specials

Follow us on Twitter

Guest Posts

Please share Science & Enterprise